CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,232 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01793805
NCT01793805N/ACompleted

NSABP Patient Registry and Biospecimen Profiling Repository

NSABP Foundation Inc·observational·Posted Feb 18, 2013·Updated Mar 31, 2022

In Brief

An observational study for Colorectal Cancer. Completed, enrolled 3,232 participants across 46 sites.

Detailed Summary

This is a study to collect and analyze tissue specimens from metastatic colorectal cancer (mCRC) patients for the development of a molecularly profiled tissue repository for the primary purpose of maintaining a patient registry for future clinical trials based on the molecular profile of the tumors. The main purpose of testing these tissue specimens is to identify genetic alterations or biomarkers associated with colorectal cancer such that if new agent(s) become available, particularly those that target these genetic alterations/biomarkers, participants may be offered the opportunity to take part in a National Surgical Adjuvant Breast and Bowel Project (NSABP) treatment protocol.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 18, 2013
Enrollment StartFeb 1, 2013
Primary CompletionMar 1, 2022
TodayJul 1, 2026
Enrollment to primary: 9.1 yearsPosted 13.4 years ago